1.Clinical outcomes and bone resection analysis of unilateral double-channel endoscopic technique in treating lumbar disc herniation
Qing-Yun XIN ; Wen-Zheng LI ; Jun-Jian HAN ; Qi-Tao LIU ; Chao FENG ; Xiu-Sheng GUO ; Jie WEI ; Jie-Fu SONG ; De-An QIN ; Deng-Jun ZHANG
China Journal of Orthopaedics and Traumatology 2024;37(3):222-227
		                        		
		                        			
		                        			Objective To explore clinical outcomes and bone resection of interlaminar fenestration decompression and u-nilateral biportal endoscopic(UBE)technique in treating lumbar disc herniation(LDH).Methods A retrospective study was performed on 105 patients with single-level LDH treated from December 2019 to December 2021.Fifty-four patients in UBE group,including 32 males and 22 females,aged from 18 to 50 years old with an average of(38.7±9.3)years old,were treated with UBE,29 patients withL4.5and 25 patients with L5S1.There were 51 patients in small fenestration group,including 27 males and 24 females,aged from 18 to 50 years old with an average of(39.9±10.0)years old,were treated with small fenestra-tion,25 patients with L4.5 and 26 patients with L5S1.Perioperative indexes,such as operation time,postoperative time of getting out of bed and hospital stay were observed and compared between two groups.Visual analogue scale(VAS)and Oswestry dis-ability index(ODI)were compared between two groups before operation and 1,3,6 and 12 months after operation,respective-ly;and modified MacNab evaluation criteria was used to evaluate clinical efficacy.Amount of bone resection and retention rate of inferior articular process laminoid complex were compared between two groups.Results All 105 patients were successfully completed operation.Both of two groups were followed up from 6 to 12 months with an average of(10.69±2.49)months.Oper-ation time,postoperative time of getting out of bed and hospital stay were(58.20±5.54)min,(2.40±0.57)dand(3.80±0.61)d in UBE group,and(62.90±7.14)min,(4.40±0.64)d and(4.40±0.64)d in small fenestrum group,respectively;and had sta-tistically difference between two groups(P<0.05).Postoperative VAS of low back and leg pain and ODI in both groups were significantly lower than those before surgery(P<0.05).VAS of lumbar pain in UBE group(1.37±0.49)score was lower than that of small fenestration group(2.45±0.64)score,and had statistically difference(t=9.745,P<0.05).Postoperative ODI in UBE group at 1 and 3 months were(28.54±3.31)%and(22.87±3.23)%,respectively,which were lower than those in small fenestra group(36.31±9.08)%and(29.90±8.36)%,and the difference was statistically significant(P<0.05).There were no significant difference in VAS and ODI between two groups at other time points(P>0.05).According to the modified MacNab evaluation criteria at the latest follow-up,49 patients got excellent result,3 good,and 2 fair in UBE group.In small fenestration group,35 patients got excellent,12 good,and 4 fair.In UBE group,amount of bone resection on L4,5 segment was(0.45±0.08)cm3 and(0.31±0.08)cm3 on the segment of L5S1.In small fenestration group,amount of bone resection on L4.5 segment was(0.57±0.07)cm3 and(0.49±0.04)cm3 on the segment of L5S1,and amount of bone resection of lower articular process laminar complex on the same segment in UBE group was less than that in small fenestration group(P<0.05).In UBE group,retention rate of laminoid complex on L4,5 segment was(0.73±0.04)and L5S1 segment was(0.83±0.03),whileL4,5segment was(0.68± 0.06)and L5S1 segment was(0.74±0.04)in small fenestration group,the lower articular process laminar complex retention rate in UBE group was higher than that in small fenestration group(P<0.05).Conclusion Both unilateral double-channel endoscopy and small fenestration of laminae could achieve good clinical results in treating LDH,but UBE has advantages of less trauma,higher eficiency,faster postoperative recovery and less damage to bone structure.
		                        		
		                        		
		                        		
		                        	
2.Epidemiological characteristics and spatial epidemiology of hand-foot-mouth disease in Hunan Province, China, from 2008 to 2019.
Jian-Hui WEI ; Rong WU ; De-Xiu XING ; Jing SHU ; Shi-Xiong HU ; Jia-Bi QIN
Chinese Journal of Contemporary Pediatrics 2021;23(11):1141-1148
		                        		
		                        			OBJECTIVES:
		                        			To investigate the epidemic situation of hand-foot-mouth disease (HFMD) in Hunan Province, China, from 2008 to 2019, as well as its spatial autocorrelation characteristics and spatial-temporal clustering, and to provide a reference for the prevention and control of HFMD in Hunan Province.
		                        		
		                        			METHODS:
		                        			Spatial autocorrelation and spatial-temporal clustering analyses were used to analyze the monitoring data of HFMD in Hunan Province from 2008 to 2019.
		                        		
		                        			RESULTS:
		                        			The epidemic situation of HFMD in Hunan Province from 2008 to 2019 showed obvious seasonal distribution, with a low incidence rate in January to March and a high incidence rate in April to July. As for population distribution, children aged 0-5 years had the highest number of HFMD cases and accounted for 95.89% (1 460 391/1 522 910) of all cases, with a mean annual incidence rate of 2 197.784/100 000, and scattered children had the highest number of cases and accounted for 82.59% (1 257 739/1 522 910) of all cases. The global spatial autocorrelation analysis showed that the onset of HFMD in Hunan Province showed a significant clustering distribution, and the local spatial autocorrelation analysis showed that the high clustering areas of HFMD were mainly the districts and counties of Changsha, Zhuzhou, and Yueyang cities. Time-space scanning showed that clustering time was mainly April to July; the cases were clustered in the northeast of Hunan Province from 2008 to 2010 and in the central part of Hunan Province from 2011 to 2019.
		                        		
		                        			CONCLUSIONS
		                        			The high incidence rate of HFMD is observed in April to July in Hunan Province. Children under 5 years of age are at a high risk of this disease. Spatial-temporal clustering is observed for the epidemic of HFMD, mainly clustered in the northeastern and central areas of Hunan Province. It is suggested that the results may be used as guidance to determine the key areas for HFMD prevention and control in Hunan Province and optimize the allocation of health resources.
		                        		
		                        		
		                        		
		                        			Child
		                        			;
		                        		
		                        			Child, Preschool
		                        			;
		                        		
		                        			China/epidemiology*
		                        			;
		                        		
		                        			Cluster Analysis
		                        			;
		                        		
		                        			Hand, Foot and Mouth Disease/epidemiology*
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Incidence
		                        			;
		                        		
		                        			Infant
		                        			;
		                        		
		                        			Spatio-Temporal Analysis
		                        			
		                        		
		                        	
3.Clinical practice guidelines for modified radical mastectomy of breast cancer: Chinese Society of Breast Surgery (CSBrs) practice guidelines 2021.
De-Chuang JIAO ; Jiu-Jun ZHU ; Li QIN ; Xu-Hui GUO ; Ya-Jie ZHAO ; Xiu-Chun CHEN ; Cheng-Zheng WANG ; Zhen-Duo LU ; Lian-Fang LI ; Shu-De CUI ; Zhen-Zhen LIU
Chinese Medical Journal 2021;134(8):895-897
4.Historical evolution and research advance in processing adjuvant--vinegar.
Yu LI ; Lian-Lin SU ; De JI ; Chun-Qin MAO ; Xiu-Mei CUI ; Cheng-Lin SUI ; Tu-Lin LU ; Xiao-Li ZHAO
China Journal of Chinese Materia Medica 2021;46(16):4083-4088
		                        		
		                        			
		                        			Processing of Chinese medicinals with vinegar is one of the characteristic processing techniques. Vinegar is vital for the quality of vinegar-processed decoction pieces. However, there have been no specified standards for adjuvants. Through consulting relevant literature and monographs, we comprehensively reviewed the historical evolution of processing with vinegar in records, selection and application of vinegar, and summarized the relevant standards and current status of vinegar as an adjuvant in China. According to the records in literature, vinegar is effective in activating blood, moving qi, dispersing blood stasis, removing toxin, promoting appetite, and nourishing the liver. Traditionally, rice vinegar is chosen in processing. Nowadays, the vinegar made from rice under solid-state fermentation should be chosen. At present, only food standards can be taken for reference for vinegar in the processing. Integrative and specific inspection indicators are lacking, so the standards for adjuvants need to be improved urgently. In addition, the inadequacy in quality control and management is also a major problem to be solved. Through literature research, we reviewed the historical evolution and research advance in vinegar to provide a reference for the standardization and further research of vinegar used in the Chinese medicinal processing.
		                        		
		                        		
		                        		
		                        			Acetic Acid
		                        			;
		                        		
		                        			Adjuvants, Pharmaceutic
		                        			;
		                        		
		                        			Drugs, Chinese Herbal
		                        			;
		                        		
		                        			Oryza
		                        			;
		                        		
		                        			Quality Control
		                        			
		                        		
		                        	
5.Plant metabolomics for studying the effect of two insecticides on comprehensive constituents of Lonicerae Japonicae Flos.
Hui-Qin PAN ; Heng ZHOU ; Shui MIAO ; De-An GUO ; Xiao-Li ZHANG ; Qing HU ; Xiu-Hong MAO ; Shen JI
Chinese Journal of Natural Medicines (English Ed.) 2021;19(1):70-80
		                        		
		                        			
		                        			Pesticides' overuse and misuse have been reported to induce ingredient variations in herbal medicine, which is now gaining attention in the medicinal field as a form of alternative medicine. To date, available studies on pesticide-induced ingredient variations of herbal medicine are limited only on a few compounds and remain most others unexamined. In this study, a plant metabolomics-based strategy was performed to systematically explore the effects of two frequently used insecticides on the comprehensive constituents of Lonicerae Japonicae Flos (LJF), the flower buds of Lonicera japonica Thunb. Field trials were designed on a cultivating plot of L. japonica with controls and treatments of imidacloprid (IMI) and compound flonicamid and acetamiprid (CFA). Unbiased metabolite profiling was conducted by ultra-high performance liquid chromatography/quadrupole-Orbitrap mass spectrometer. After data pretreatment by automatic extraction and screening, a data matrix of metabolite features was submitted for statistical analyses. Consequently, 29 metabolic markers, including chlorogenic acids, iridoids and organic acid-glucosides were obtained and characterized. The relative quantitative assay was subsequently performed to monitor their variations across flowering developments. This is the first study that systematically explored the insecticide-induced metabolite variations of LJF while taking into account the inherent variability of flowering development. The results were beneficial for holistic quality assessment of LJF and significant for guiding scientific use of pesticides in the large-scale cultivation.
		                        		
		                        		
		                        		
		                        	
6.Mechanism of tanshinone IIA to prevent spontaneous breast cancer in mice
Yuan WANG ; Xiao-feng LI ; Ye SUN ; Jun-de XU ; Yi-chuang WU ; Peng WAN ; Rui DENG ; Xiu-qin ZHENG ; Xiao-man LI ; Yang ZHAO ; Yin LU ; Yuan-yuan WU
Acta Pharmaceutica Sinica 2021;56(12):3277-3284
		                        		
		                        			
		                        			 To explore the effect of tanshinone IIA (TanIIA) on the occurrence and development of breast cancer, we employed the mouse mammary tumor virus-polyomavirus middle T antigen (MMTV-PyMT) transgenic mice as a spontaneous breast cancer mouse model. Animal welfare and experimental procedures were in accordance with the regulations of the Animal Ethics Committee of Nanjing University of Chinese Medicine. The animals were divided into control group, low-dose TanIIA treatment group (30 mg·kg-1·day-1), and high-dose TanIIA treatment group (60 mg·kg-1·day-1). The treatment was administered orally and daily for 5 weeks. The mice were sacrificed after final treatment. Mammary gland and lung were collected for histopathology studies. We evaluated the chemoprophylaxis effect of TanIIA on breast cancer in mice according to the pathological characteristics of breast cancer at different stages of development. Immunofluorescence staining were employed for blood vessel analysis. The expression levels of E-cadherin, proliferating nuclear antigen (PCNA), and oncogene c-Myc were detected by immunohistochemistry. Flow cytometry was used to analyze cell cycle and Cytoscape was used to construct drug-disease protein-protein interaction (PPI) network. Our results showed that TanIIA inhibits breast tumor progression by delaying malignancy from adenoma to early carcinoma, and inhibits blood vessel formation during tumor development. TanIIA (60 mg·kg-1·day-1) inhibits the expression levels of PCNA and c-Myc, upregulates the expression of E-cadherin. In addition, cell cycle experiments showed that the cell cycle of PyMT primary mammary cells in the high-dose TanIIA group was arrested in the G0/G1 phase. Our study demonstrated that TanIIA can significantly inhibit breast tumor progression in MMTV-PyMT mouse model, which may be related to the inhibition of angiogenic switch and cell cycle arrest. 
		                        		
		                        		
		                        		
		                        	
7.Research Progress on Antidepressant Pathway and Active Ingredients of Xiaoyaosan and Its Analogous Prescriptions
Chuan-peng LI ; Yu LIU ; Pin-qiu WEI ; Hai-bin WU ; Xiu-de QIN
Chinese Journal of Experimental Traditional Medical Formulae 2020;26(6):243-250
		                        		
		                        			
		                        			Depression is a psychiatric disease that seriously affects human life in the context of rapid social development and increased living pressure, and brings serious healthproblems and economic burdens to human society.Traditional Chinese medicine has a long history in the treatment of depression, and Xiaoyaosan has been repeatedly confirmed as a classic prescription for the intervention in depression, but its antidepressant mechanism and its active ingredients are still unclear.Through the search of China Knowledge Network(CNKI) and PubMed database, the literature and data on the clinical and mechanism research of Xiaoyaosan and its analogous prescriptions on depression in the past 10 years are systematically sorted out.It is found that Xiaoyao San and its analogous prescriptions are mainly focusing on the following aspects: regulating hypothalamic-pituitary-gonad, hypothalamic-pituitary-thyroid, and hypothalamic-pituitary-adrenal axis, affecting 5-hydroxytryptamine(5-HT), norepinephrine(NE) neurotransmitters in hippocampus, interfering with inflammatory reaction process, modulating the BDNF/CREB signaling pathway, regulating intestinal flora and gastrointestinal function, regulating endothelial window foramen of hepatic sinus, repairing chronic stress-induced blood-brain barrier permeability, affecting autophagy to reduce neuronal apoptosis, and regulating the leukoplakia-nuclear adrenal gland (LC-NE) system to play an antidepressant role.The main active ingredient including, saikosaponin A which could down-regulate interleukin expression level, saikosaponin D which alleviates HPA axis dysfunction, quercetin which inhibits corticotropin-releasing-factor(CRF) mRNA expression, paeoniflorin which regulates neurotransmitters, and paeoni lactone which inhibits hyperfunction of HPA axis Glycosides, reduce inflammatory cytokines, atractylenolide I, atractylenolide Il, atractylenolide Ill, which could reduce the expression of pro-inflammatory cytokine mRNA and inhibit NF-
		                        		
		                        	
8.Mycoplasma pneumoniae Macrolide Resistance and MLVA Typing in Children in Beijing, China, in 2016: Is It Relevant?
Wei Hai DOU ; Jun Xiu TIAN ; Li De XIN ; Ran WEI ; Wei ZHOU ; Hong WANG ; Guang Xuan QIN ; Yan Jun SHAO ; Ping Bao XU ; Xia Li GE ; Wei Da SHI
Biomedical and Environmental Sciences 2020;33(12):916-924
		                        		
		                        			
		                        			Objective The aim of this study is to investigate the macrolide resistance rate and molecular type withmultiple-locus variable-number tandem-repeat analysis (MLVA) of Mycoplasma pneumoniae of Beijing in 2016 in pediatric patients. Methods Real-time quantitative polymerase chain reaction (PCR) was used to identify M. pneumoniae, and MLVA was performed. The domain V of the 23S rRNA was sequenced to detect macrolide-resistant point mutations. We also investigated the activities of antibiotics against M. pneumoniae isolates in vitro. Results The PCR detection rate of M. pneumoniae in children in Beijing was 40%, and the macrolide resistance rate was 66%. The A2063G mutation in the 23S rRNA V region is the dominant mutation (137/146, 93.84%), whereas the A2064G mutation is rare (9/146, 6.16%). Seventy-three samples were typed successfully by MLVA typing, including 86.3% (63/73) were MLVA type 4-5-7-2, and 13.7% (10/73) were MLVA type 3-5-6-2. No other types were found. No strains were resistant to levofloxacin or tetracycline. Conclusion In 2016, a specific decrease in the macrolide resistance rate occurred in Beijing. The detection rate and macrolide resistance rate of outpatients are lower than those of inpatients. The A2063G mutants M. pneumoniae have high levels of resistance to erythromycin and azithromycin. The primary MLVA type is 4-5-7-2, followed by 3-5-6-2. No other MLVA types were detected. No strains resistant to tetracycline or levofloxacin were found in vitro.
		                        		
		                        		
		                        		
		                        	
9.Effect of Qinghuang Powder () Combined with Bupi Yishen Decoction () in Treating Patients with Refractory Cytopenia with Multilineage Dysplasia through Regulating DNA Methylation.
Qing-Bing ZHOU ; Xiao-Hong YANG ; Hong-Zhi WANG ; De-Xiu WANG ; Yong-Gang XU ; Xiao-Mei HU ; Feng-Qin XU ; Rou MA
Chinese journal of integrative medicine 2019;25(5):354-359
		                        		
		                        			OBJECTIVE:
		                        			To explore the effect of Qinghuang Powder (QHP,()combined with Bupi Yishen Decoction (BPYS, ) on myelodysplastic syndromes (MDS) patients with refractory cytopenia with multilineage dysplasia (RCMD) and determine the change of DNA methylation in MDS-RCMD patients after the treatment of Chinese medicine formula.
		                        		
		                        			METHODS:
		                        			All 308 MDS-RCMD patients were treated with QHP combined with BPYS for 2 months at least, absolute neutrophil count (ANC), hemoglobin (Hb), platelets (PLT), primitive bone marrow cells and chromosome karyotype were chosen as the main evaluation indexes to analyze the treatment effect according to criteria from the MDS International Working Group. Then 43 bone marrow samples from 15 MDS-RCMD patients and 28 healthy donors were obtained for the examination of DNA methylation. Gene Ontology (GO) and Pathway analysis were applied to analyze the methylation data.
		                        		
		                        			RESULTS:
		                        			The overall MDS response rate to QHP was 61.68% (190/360) including hematologic improvement-neutrophil (HI-N) or hematologic improvement-erythroid (HI-E) or hematologic improvement-platelet (HI-P). Patients with anemia had a better response rate than patients with neutropenia or thrombocypenia (55.88% vs 31.54% or 55.88% vs. 36.9%). The DNA methylation microarray analysis disclosed that 4,257 hypermethylated genes were demethylated upon the treatment with QHP and BPYS. GO analysis and Pathway analysis showed that these demethylated genes were involved in a lot of tumor-related pathways and functions.
		                        		
		                        			CONCLUSIONS
		                        			QHP combined with BPYS could effectively treat MDS-RCMD patients through hematologic improvement (HI-N, HI-P or HI-E) and PLT and RBC transfusion independence due to the demethylation, thereby providing another choice for the treatment of patients with MDS-RCMD.
		                        		
		                        		
		                        		
		                        			Arsenicals
		                        			;
		                        		
		                        			administration & dosage
		                        			;
		                        		
		                        			pharmacology
		                        			;
		                        		
		                        			therapeutic use
		                        			;
		                        		
		                        			Cell Lineage
		                        			;
		                        		
		                        			drug effects
		                        			;
		                        		
		                        			DNA Methylation
		                        			;
		                        		
		                        			drug effects
		                        			;
		                        		
		                        			Demethylation
		                        			;
		                        		
		                        			Drugs, Chinese Herbal
		                        			;
		                        		
		                        			administration & dosage
		                        			;
		                        		
		                        			pharmacology
		                        			;
		                        		
		                        			therapeutic use
		                        			;
		                        		
		                        			Female
		                        			;
		                        		
		                        			Gene Ontology
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Leukocyte Disorders
		                        			;
		                        		
		                        			drug therapy
		                        			;
		                        		
		                        			genetics
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Middle Aged
		                        			;
		                        		
		                        			Powders
		                        			;
		                        		
		                        			Treatment Outcome
		                        			
		                        		
		                        	
10.Effect of Qingnao Yizhi on expression of NogoA and Rho-associated kinase in hippocampus of vascular dementia rats
Jin-Qiang ZHU ; Shao-Qian YUE ; Lin LI ; Xiu-De QIN
The Chinese Journal of Clinical Pharmacology 2018;34(9):1081-1084
		                        		
		                        			
		                        			Objective To investigate the effect of Qingnao Yizhi formula (QNYZF) on NogoA and Rho-associated kinase(ROCK-2)expression in hippocampus of vascular dementia (VaD) of rats.Methods The rat model of VaD was established by bilateral ligation of the common carotid artery (2-VO).The male Sprague-Dawley rats were randomly divided into 6 groups,each group had 6 rats:sham operation group,model group,control group,experimental-L,experimental-M and experimental-H groups.The sham operation group and model group were fed with equal volume of 0.9% NaCl;the control group were fed with donepezil hydrochloride 0.52 mg · kg-1 · d-1;the experimental-L,experimental-M and experimental-H groups were fed with QNYZF 3,6,12 g · kg-1 · d-1,respectively for 4 weeks.After 4 weeks of intragastric administration,the heart was perfused and the hippocampus of the brain was rapidly taken,and then the protein expression of NogoA and ROCK-2 in hippocampus were detected by immunohistochemistry and reverse transcription-PCR respectively.Results The relative gray values of NogoA + cells in the hippocampus:the sham operation group,model group,control group,experimental-L,experimental-M and experimental-H groups were 435.30 ± 127.98,5365.94 ± 1351.96,1585.92 ±360.64,1953.77 ±653.58,2300.94 ±742.25,1681.35 ±437.87.Comparison between the sham group and the model group,the difference was significantly increased (P < 0.05);comparison between the model group and control group,the difference was significantly increased (P < 0.05);but experimental-L,experimental-M and experimental-H groups was not statistically significant (P > 0.05).The relative gray values of ROCK -2+ cells in hippocampus of rats:the 6 groups were 68.11 ± 12.58,556.79 ± 141.85,130.20 ± 31.05,357.24 ± 100.07,193.39 ±40.79 and 503.64 ±219.87,respectively.Comparison between the sham group and the model group,the difference was significantly increased (P < 0.05);comparison between the control group,experimental-M group and model group,the difference was significantly increased (P < 0.05,P < 0.01).Conclusion QNYZF can promote synaptic remodeling of neurons by inhibiting NogoA-NgR/Rho-ROCK signaling pathway.
		                        		
		                        		
		                        		
		                        	
            
Result Analysis
Print
Save
E-mail